Immune checkpoint inhibitors: Real-world experience from india in advanced solid cancers that have progressed on chemotherapy
Context: The immune checkpoint inhibitors (ICIs) nivolumab and pembrolizumab have shown dramatic efficacy with low toxicity in international studies of advanced solid cancers. No published Indian experience with ICIs exist other than isolated case reports. Aims: The aim of this study is to evaluate...
Main Authors: | Vineet Govinda Gupta, Ranga Rao Rangaraju, Waseem Abbas, Peush Bajpai, Ruchika Khetrapal |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019-01-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=1;spage=65;epage=68;aulast=Gupta |
Similar Items
-
Evolving role of immunotherapy in head-and-neck cancers: A systemic review
by: Raajit Chanana, et al.
Published: (2018-01-01) -
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
by: Hyera Kim, et al.
Published: (2020-08-01) -
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
by: Jeffrey M. Conroy, et al.
Published: (2019-01-01) -
Cancer immunotherapy experience in the Integral Oncology Centre “Diana Laura Riojas de Colosio”, Médica Sur Hospital
by: Ricardo Fernández-Ferreira, et al.
Published: (2019-12-01) -
Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
by: McCusker MG, et al.
Published: (2020-04-01)